Kelly L Warfield (Kelly Warfield)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Sentinel Lymph Node

Top Venues

International journal of toxicology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Demetrius Matassov, Lisa Evans DeWald, Stefan Hamm, Rebecca M Nowak, Cheryl S Gerardi, Theresa E Latham, Rong Xu, Amara Luckay, Tracy Chen, Marc Tremblay, Jeffry Shearer, Melissa Wynn, John H Eldridge, Kelly L Warfield, Kevin Spurgers
Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus. Vaccines 12 (8) (2024)
Saravanan Raju, Lucas J Adams, James T Earnest, Kelly L Warfield, Lo Vang, James E Crowe, Daved H Fremont, Michael S. Diamond
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans. Science translational medicine 15 (696) (2023)
Saravanan Raju, Lucas J Adams, James T Earnest, Kelly L Warfield, Lo Vang, James E Crowe, Daved H Fremont, Michael S. Diamond
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans. Science translational medicine 15 (696) (2023)
Natalie D Collins, Shannon Beaty, Elana Wallace, Yuanzhang Li, Mark Sanborn, Yu Yang, Anima Adhikari, Paul Shabram, Kelly L Warfield, Nicos Karasavvas, Robert A Kuschner, Jun Hang
Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine. Vaccines 11 (7) (2023)
Jeffry Shearer, Gary Wolfe, Aruna Sampath, Kelly L Warfield, Brian Kaufman, Urban Ramstedt, Anthony M Treston
Investigational New Drug Enabling Nonclinical Safety Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent. International journal of toxicology 41 (3) (2022)
Jeffry Shearer, Gary Wolfe, Aruna Sampath, Kelly L Warfield, Brian Kaufman, Urban Ramstedt, Anthony M Treston
Investigational New Drug Enabling Nonclinical Safety Pharmacology Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent. International journal of toxicology 41 (3) (2022)